Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
| PALI Stock | USD 2.46 0.04 1.65% |
Under 50% of Palisade Bio's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Palisade Bio suggests that some traders are interested. Palisade Bio's investing sentiment shows overall attitude of investors towards Palisade Bio.
Palisade |
Collaboration advancing Palisade Bios precision medicine approach through access to cutting-edge expertise and tools in bioinformatics Candidate PDE4-related biomarkers overlapping with UC pathophysiology have been identified and innovative selection strategy development is underway Carlsbad, CA, June 21, 2024 -- Palisade Bio, Inc. , a biopharmaceutical company focused on developing and advancing novel therapeutics
Read at finance.yahoo.com
 |
Palisade Bio Fundamental Analysis
We analyze Palisade Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Palisade Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Palisade Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Palisade Bio is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Palisade Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Palisade Bio stock to make a market-neutral strategy. Peer analysis of Palisade Bio could also be used in its relative valuation, which is a method of valuing Palisade Bio by comparing valuation metrics with similar companies.
Peers
Palisade Bio Related Equities
| IMMX | Immix Biopharma | 7.11 | ||||
| ENVB | Enveric Biosciences | 3.13 | ||||
| PHIO | Phio Pharmaceuticals | 3.03 | ||||
| NBY | NovaBay Pharmaceuticals | 1.69 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| UNCY | Unicycive Therapeutics | 1.47 | ||||
| ZVSA | ZyVersa Therapeutics | 3.60 | ||||
| CYTO | Altamira Therapeutics | 4.76 |
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |